# A Study to Evaluate the Pharmacokinetics and Safety of Diluted vs. Undiluted Intravenous DA-5217 in Healthy Adult Subjects

> **NCT07027982** · PHASE1 · COMPLETED · sponsor: **Dong-A ST Co., Ltd.** · enrollment: 32 (actual)

## Conditions studied

- Healthy Adults

## Interventions

- **DRUG:** Diluted Intravenous DA-5217
- **DRUG:** Undiluted Intravenous DA-5217

## Key facts

- **NCT ID:** NCT07027982
- **Lead sponsor:** Dong-A ST Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-07-16
- **Primary completion:** 2025-08-14
- **Final completion:** 2025-08-14
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2025-08-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07027982

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07027982, "A Study to Evaluate the Pharmacokinetics and Safety of Diluted vs. Undiluted Intravenous DA-5217 in Healthy Adult Subjects". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07027982. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*